Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0001415889-24-003404 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | 2023-02-08 | TVRD | Maynard Ryan D | CFO | S - Sale | $0.53 | -5,488 | 8,012 | -41% | -$2,909 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-08 | S | D | 5,488 | $0.53 | 8,012 | D | — | — |